The report points to a number of factors
driving big pharma companies» struggles with netting strong returns, including a dearth of late - stage pipeline candidates and diversified product portfolios that aren't necessarily spreading risk.
RB: Your latest smash, Vaccine Nation, is interesting to me, having read about some of the ugly science behind vaccines, and the massive financial interests that
drive big pharma.
Not exact matches
A number of
big pharma will continue to
drive M&A activity through 2015 & 2016 where larger companies such as Pfizer and Teva have both the appetite and the cashflow to look at investments that support existing divisions.